A combination of immune cell types identified through ensemble machine learning strategy detects altered profile in

Marilen Benner1, Dorien Feyaerts1, Alejandro Lopez-Rincon2

  • 1Radboud Institute of Molecular Life Sciences, Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, the Netherlands.

F&S Science
|May 13, 2022
PubMed

Insights

Immune cell profiles in peripheral and menstrual blood can distinguish women with recurrent pregnancy loss. Menstrual blood offers a promising, noninvasive method for assessing reproductive health and immune function.

Area of Science:

  • Reproductive Immunology
  • Immunology
  • Flow Cytometry

Background:

  • Recurrent pregnancy loss (RPL) affects women without clear causes.
  • Understanding the immune system's role in RPL is crucial for diagnosis and treatment.
  • Comparing immune profiles in different blood sources may reveal novel biomarkers.

Purpose of the Study:

  • To compare the immunologic profiles of peripheral blood and menstrual blood (MB) in women with RPL versus controls.
  • To identify specific immune cell subsets that can differentiate between these groups.
  • To explore the potential of MB as a noninvasive diagnostic tool for reproductive health.

Main Methods:

  • An explorative case-control study design was employed.
  • Flow cytometry was used for cross-sectional assessment of immunologic profiles.
  • Machine learning classifiers in an ensemble strategy with recursive feature selection were applied to analyze immune cell data.

Main Results:

  • Peripheral blood analysis identified 4 key cell types differentiating cohorts (e.g., B cells, CD8+ T cells, NK cells).
  • Menstrual blood analysis identified 6 cell types plus age as discriminators (e.g., regulatory T cells, B cells, NK cells).
  • Both peripheral blood and MB analyses achieved high accuracy (>0.8 AUC) in cohort classification.

Conclusions:

  • Combinations of immune cell subsets can robustly identify women with RPL, suggesting diagnostic potential.
  • Menstrual blood provides a noninvasive and valuable source for assessing and monitoring reproductive health.
  • Further research into these immune parameters could lead to improved diagnostics and management of RPL.
Abstract